GeneFluidics Inc. (GeneFluidics) is a privately held novel technology company. The company is principally engaged in commercialization of a novel molecular analysis platform that integrates bionanotechnology and microfluidics. The platform has two distinct and synergistic components namely electrochemical detection, which is embedded in a multichannel reader and plastic sensor chips, and automated sample preparation that is embedded in microfluidic cartridges and associated with reader fluidic controls. By the integration of these two components, the rapid detection and quantification of genetic material is possible. By using this platform, the complex tests can be done by skilled technicians in a laboratory. The product portfolio of the company includes proteus and asklepios. GeneFluidics is headquartered at Monterey Park in California, the US.

Street: 
2540 Corporate Place
City: 
Monterey Park
Postcode: 
91754
Federal State : 
United States
WebSite: 
www.genefluidics.com
Fax: 
1-323-2690988

Company Index Score

Current Index Score Historical Index Score
  • GeneFluidics Inc. currently scores 50 % in the index.
  • GeneFluidics Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • GeneFluidics Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets